Literature DB >> 17164367

The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region.

Alireza Ansary-Moghaddam1, Rachel Huxley, Federica Barzi, Carlene Lawes, Takayoshi Ohkubo, Xianghua Fang, Sun Ha Jee, Mark Woodward.   

Abstract

BACKGROUND: Pancreatic cancer accounts for about 220,000 deaths each year. Known risk factors are smoking and type 2 diabetes. It remains to be seen whether these risk factors are equally important in Asia and whether other modifiable risk factors have important associations with pancreatic cancer.
METHODS: An individual participant data analysis of 30 cohort studies was carried out, involving 420,310 Asian participants (33% female) and 99,333 from Australia/New Zealand (45% female). Cox proportional hazard models, stratified by study and sex and adjusted for age, were used to quantify risk factors for death from pancreatic cancer.
RESULTS: During 3,558,733 person-years of follow-up, there were 324 deaths from pancreatic cancer (54% Asia and 33% female). Mortality rates (per 100,000 person-years) from pancreatic cancer were 10 for men and 8 for women. The following are age-adjusted hazard ratios (95% confidence interval) for death from pancreatic cancer: for current smoking, 1.61 (1.12-2.32); for diabetes, 1.76 (1.15-2.69); for a 2-cm increase in waist circumference, 1.08 (1.02-1.14). All three relationships remained significant (P < 0.05) after adjustment for other risk factors. There was no evidence of heterogeneity in the strength of these associations between either cohorts from Asia and Australia/New Zealand or between the sexes. In men, the combination of cigarette smoking and diabetes more than doubled the likelihood of pancreatic cancer (2.47; 95% confidence interval, 1.17-5.21) in both regions.
CONCLUSIONS: Smoking, obesity, and diabetes are important and are potentially modifiable risk factors for pancreatic cancer in populations of the Asia-Pacific region. Activities to prevent them can be expected to lead to a major reduction in the number of deaths from this cancer, particularly in Asia with its enormous population.

Entities:  

Mesh:

Year:  2006        PMID: 17164367     DOI: 10.1158/1055-9965.EPI-06-0368

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Steven Gallinger; Sean P Cleary
Journal:  Carcinogenesis       Date:  2012-02-02       Impact factor: 4.944

Review 3.  Tobacco and the risk of pancreatic cancer: a review and meta-analysis.

Authors:  Simona Iodice; Sara Gandini; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

4.  Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

Authors:  Li Jiao; Amy Berrington de Gonzalez; Patricia Hartge; Ruth M Pfeiffer; Yikyung Park; D Michal Freedman; Mitchell H Gail; Michael C R Alavanja; Demetrius Albanes; Laura E Beane Freeman; Wong-Ho Chow; Wen-Yi Huang; Richard B Hayes; Jane A Hoppin; Bu-Tian Ji; Michael F Leitzmann; Martha S Linet; Cari L Meinhold; Catherine Schairer; Arthur Schatzkin; Jarmo Virtamo; Stephanie J Weinstein; Wei Zheng; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

Review 5.  Screening and early detection of pancreatic cancer in high risk population.

Authors:  Ming-Chu Chang; Jau-Min Wong; Yu-Ting Chang
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 6.  Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Kaustav Majumder; Arjun Gupta; Nivedita Arora; Preet Paul Singh; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-14       Impact factor: 11.382

7.  Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study.

Authors:  Noel T Mueller; Andrew Odegaard; Kristin Anderson; Jian-Min Yuan; Myron Gross; Woon-Puay Koh; Mark A Pereira
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

Review 8.  Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.

Authors:  Crystal C Lipsey; Adriana Harbuzariu; Danielle Daley-Brown; Ruben R Gonzalez-Perez
Journal:  World J Methodol       Date:  2016-03-26

9.  Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma.

Authors:  Anna Evans Phillips; Nilesh Shah; Amir A Borhani; Dhiraj Yadav; Randall E Brand
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

10.  Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.

Authors:  Cari L Meinhold; Amy Berrington de Gonzalez; Demetrius Albanes; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2008-12-13       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.